Multidimensional family therapy decreases the rate of externalising behavioural disorder symptoms in cannabis abusing adolescents: Outcomes of the INCANT trial

Background: US-based trials have shown that Multidimensional Family Therapy (MDFT) not only reduces substance abuse among adolescents, but also decreases mental and behavioural disorder symptoms, most notably externalising symptoms. In the INCANT trial, MDFT decreased the rate of cannabis dependence among Western European youth. We now focus on other INCANT outcomes, i.e., lessening of co-morbidity symptoms and improvement of family functioning.Methods: INCANT was a randomised controlled trial comparing MDFT with individual therapy (IP) at and across sites in Berlin, Brussels, Geneva, The Hague, and Paris. We recruited 450 boys and girls aged 13 up to 18 years with a cannabis use disorder, and their parent(s), and followed them for 12 months. Mental and behavioural characteristics (classified as 'externalising' or 'internalising') and family conflict and cohesion were assessed.Results: From intake through 12 months, MDFT and IP groups improved on all outcome measures. Models including treatment, site, and referral source showed that MDFT outperformed IP in reducing externalising symptoms.Adolescents were either self-referred to treatment (mostly on the initiative from people close to the teen) or referred under some measure of coercion by an external authority. These two groups reacted equally well to treatment.Conclusions: Both MDFT and IP reduced the rate of externalising and internalising symptoms and improved family functioning among adolescents with a cannabis use disorder. MDFT outperformed IP in decreasing the rate of externalising symptoms. Contrary to common beliefs among therapists in parts of Western Europe, the 'coerced' adolescents did at least as well in treatment as the self-referred adolescents.MDFT shows promise as a treatment for both substance use disorders and externalising symptoms

Gevraagd: betere informatie van de overheid over dreigende ontwikkelingen in het aanbod van drugs

Om het potentieel gevaarlijk aanbod van oude en nieuwe drugs te kunnen opsporen en daarop snel te reageren, werken de lidstaten van de Europese Unie tegenwoordig met een ‘early warning system’. Zo’n systeem moet goed kunnen communiceren. Wij onderzochten de communicatieve prestaties van het Belgische systeem. Het kan beter, zowel wat algemene persberichten betreft als de interactie met specifieke doelgroepen

The Plinius Major Society.

The Plinius Maior Society is an international contact group held by European university clinicians involved in the evaluation and the treatment of alcoholic patients. His major aim is to define common guidelines on these topics.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Cliniques de psychologie médicale

2e édition 1992-19932e Doctorat Médecineinfo:eu-repo/semantics/published

Doxepin i.m. in the treatment of depression and anxiety

The antidepressant and anxiolytic activity of Sinequan (doxepin) IM in depressive/anxious patients was evaluated in a group of 30 inpatients. After a 6 day treatment, the biphasic activity of the drug is already clearly seen, since the improvement of the depressive state, of the mood and of the anxiety (Hamilton depression scale) is approximately 50%. Compared with amitriptyline, no significant difference is seen, apart from a tendency to cause fewer side effects. Because of changes in the mood and anxiety levels which are quite parallel in the first 6 days of treatment, it is suggested that these 2 variables are closely linked in the depression/anxiety states, an observation which raises the problem of how to grade them specifically in psychopharmacological trials.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

PROFIL THERAPEUTIQUE DU CHLORHYDRATE DE BUTRIPTYLINE EN PRATIQUE PSYCHIATRIQUE AMBULATOIRE

The use of butriptyline in general psychiatric practice has demonstrated the anti-depressive and anxiolytic properties of this psychotropic drug. Seventy five per cent of the depressed patients showed a definite improvement after six weeks of treatment. This improvement reached 50% after 3 weeks, when measured with the Hamilton Rating Scale for Depression and the Self-rating Scale of Zung. Side effects were minimal at the usual dose of 75 mg/day and disappeared while treatment continued. Only in exceptional cases was it necessary to reduce the dose. Because of its convenient dosage schedule and good anti-depressive and tranquillizing properties, butriptyline appears to be a useful psychotropic drug, not only for the specialist, but also for the general practitioner in the treatment of depressed patients seen in daily practice.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Psychologie

SYL-2953 = Fascicule 1 ;SYL-2954 = Fascicule 31 édition 1 tirage Année Académique 1979-19802eme C.S.D.info:eu-repo/semantics/published

Psychologie

2e candidature sciences dentaires, Faculté de Médecine - U.L.B. - PSYC 074info:eu-repo/semantics/published

PSYCHOTHERAPIE DYNAMICO-COMPORTEMENTALE DE L'ALCOOLISME CHRONIQUE: CONCEPTS ET PRATIQUE

The 'dynamic-behavioral' concept of alcoholism is based on the analysis of the contingencies associated with alcohol intake. The therapy makes use of behavioral modification techniques focused on both the individual and his drinking behavior.SCOPUS: NotDefined.jinfo:eu-repo/semantics/publishe